PetVivo Holdings, Inc. (PETV)
PetVivo Holdings, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Edina, MN, US. The stock last traded at $0.84, down 0.12% on the session, giving a market capitalisation of $31.5M. On trailing twelve-month figures it carries a trailing P/E of -2.68, a net margin of -827.3%. Its beta of 1.24 implies it has historically moved more than the broad market.
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
PetVivo Holdings, Inc. is most often compared with the following Healthcare names: